Global Neurological Diagnostics Market: Trends, Growth Drivers, and Future Outlook

 

The Global Neurological Diagnostics Market has been witnessing robust growth, driven by rising neurological disease prevalence, increasing technological advancements, and greater government focus on early diagnosis. According to recent market research, the sector was valued at USD 13.89 billion in 2022 and is projected to reach USD 24.96 billion by 2030, expanding at a CAGR of 7.6% between 2023 and 2030. This steady growth trajectory reflects the heightened need for advanced tools to diagnose complex neurological disorders with accuracy and precision.

 


Market Overview

Neurological diagnostics involve a series of sophisticated tests and tools used to assess the health of the nervous system. These tests help evaluate motor and sensory functions, speech and hearing ability, coordination, vision, and balance. They play a critical role in identifying conditions such as Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, and various genetic neurological disorders.

Neurological disorders remain a rising global challenge. The World Health Organization (WHO) estimates that the number of individuals living with neurological diseases will increase from 95 million in 2015 to 103 million by 2030, amplifying the need for accurate diagnostics. Furthermore, strategic collaborations, technological breakthroughs, and increasing product approvals are helping manufacturers enhance diagnostic capabilities.

Download Sample

Market Segmentation

By Type

  • Genomic
  • Proteomic
  • Metabolomic
  • Imaging
  • Others

In 2022, the Proteomic segment held the highest revenue share of over 32%, followed by the Genomic segment. The rising adoption of precision medicine and personalized diagnostics is contributing significantly to this trend. Proteomics helps identify disease-related protein biomarkers, enabling early diagnosis and personalized treatment pathways tailored to an individual’s genetic predisposition.

 

By Technology

Neuroimaging Technologies

  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Nuclear Medicine Imaging (PET, SPECT)
  • Near‐Infrared Spectroscopic Imaging (NIRS)
  • Electroencephalography (EEG)
  • Magnetoencephalography (MEG)
  • Voxel-based Morphometry (VBM)

In Vitro Diagnostics

  • Biomarkers
  • Biopsy
  • Others

Neuroinformatics

The imaging technology segment remains the largest revenue contributor and is expected to maintain substantial growth throughout the forecast period. This is attributed to rising awareness of imaging technologies, increased adoption of diagnostic imaging systems in hospitals and surgical centers, and growing investments from medical device manufacturers. Additionally, the strong demand for epilepsy diagnostics is encouraging companies to develop advanced imaging tools.

 

By Disease Indication

  • Genetic Neurological Disorders
    • Alzheimer’s Disease
    • Parkinson’s Disease
    • Amyotrophic Lateral Sclerosis
    • Huntington’s Disease
    • Others
  • Immunological Neurological Disorders
    • Multiple Sclerosis
    • Others
  • Paraproteinemic Neuropathies
  • Paraneoplastic Syndrome
  • Others

In 2022, neurodegenerative diseases accounted for the largest market share due to the growing incidence of dementia, Parkinson’s disease, Huntington’s disease, and related disorders. Early and accurate diagnosis remains crucial in managing these conditions, driving higher demand for neurological examination procedures.

 

By End-User

  • Hospitals and Surgery Centers
  • Neurology Centers
  • Diagnostic Laboratories & Imaging Centers
  • Research Laboratories & Academic Institutes
  • Ambulatory Care Centers
  • Pharmaceutical and Biotechnology Companies
  • Others

The hospitals and clinics segment is projected to dominate the market owing to the availability of advanced diagnostic equipment and improved treatment facilities. Meanwhile, diagnostic laboratories and imaging centers continue to experience strong growth due to expanding healthcare infrastructure and increased R&D focused on neurodegenerative conditions.

Enquire Before Buying

Key Market Drivers

1. Rising prevalence of neurological disorders

A globally aging population and increasing awareness of neurological health have led to higher demand for diagnostic services.

2. Technological advancements

Innovations in MRI, CT, EEG, PET, and biomarker-based testing are transforming diagnostic accuracy and speed.

3. Government initiatives

Several countries are investing in neurological disease research, screening programs, and healthcare infrastructure.

4. Strategic collaborations and product approvals

Partnerships between biotechnology companies, research institutes, and diagnostic manufacturers are accelerating innovation.

Buy Now

Key Players in the Global Neurological Diagnostics Market

  1. GE HealthCare
  2. Koninklijke Philips N.V.
  3. Siemens Healthineers
  4. Hitachi Ltd.
  5. Canon Inc.
  6. Lifelines Neuro
  7. Natus Medical Incorporated
  8. F. Hoffmann-La Roche Ltd.
  9. FUJIFILM Holdings Corporation
  10. Mitsar Co. LTD

These companies are actively focusing on product innovation, strategic alliances, and portfolio expansion to strengthen their market positions.

 

Comments

Post a Comment

Popular posts from this blog

🌍 Global Fruit Picking Robots Market: Revolutionizing the Future of Agriculture with Automation 🤖🍎

Image
  The Global Fruit Picking Robots Market is transforming the way we harvest fruits — bringing precision, speed, and efficiency to one of the most labour-intensive sectors. Valued at USD 650 million in 2022 , the market is projected to reach an impressive USD 1,610.53 million by 2030 , growing at a CAGR of 12.01% (2023–2030) . As labour shortages and the need for sustainable farming practices continue to challenge traditional agriculture, fruit-picking robots are emerging as the next big leap in agritech innovation . Download Sample  ⚙️ Key Market Drivers 1️ ⃣ Technological Advancements in Agriculture Automation and AI are revolutionizing farming. Fruit-picking robots leverage computer vision, LiDAR, infrared sensors , and machine learning to recognize ripe fruits, navigate fields, and avoid obstacles. ·        Robotic arms with soft grippers allow delicate handling. ·        Cloud connectivity prov...
Read more

🌍 Global Next-Generation Biomanufacturing Market: Revolutionizing the Future of Biopharmaceutical Production

Image
  The Global Next-Generation BiomanufacturingMarket is poised for rapid transformation, fueled by technological innovation, automation, and rising biologics demand. Next-generation biomanufacturing represents a paradigm shift in how biologics and biosimilars are produced, emphasizing efficiency, scalability, flexibility, and cost-effectiveness . This evolution integrates cutting-edge automation, digital bioreactors, and single-use systems to streamline production while maintaining the highest quality and compliance standards.   🔬 What is Biomanufacturing? Biomanufacturing is the process of producing commercially valuable biomolecules using biological systems such as microbial, animal, or plant cells. These products find wide applications in pharmaceuticals, food processing, industrial enzymes, and biotechnology research . The next generation of biomanufacturing leverages genetic engineering, automation, and data-driven process control to meet growing global demand...
Read more

Global Tumor Biomarker Test Kits Market: Growth Drivers, Segment Analysis & Future Outlook (2023–2030)

Image
  The Global Tumor Biomarker Test Kits Market , valued at USD 13.1 billion in 2022 , is projected to reach USD 29.76 billion by 2030 , growing at an impressive CAGR of 10.8% during the forecast period (2023–2030). Tumor biomarker test kits play a crucial role in the early detection, monitoring, and personalized treatment of cancers, making them an indispensable component of modern healthcare systems. Understanding Tumor Biomarker Test Kits Biomarkers are biological indicators that reveal the presence or progression of disease. Tumor biomarker test kits detect changes in: Genes Proteins Other biological molecules These kits enable early detection of cancer, monitoring of disease progression, and evaluation of treatment efficiency. When paired with targeted therapies, these tests are often referred to as companion diagnostics , forming a key pillar of precision medicine . Download Sample Market Growth Drivers 1. Rising Global Cancer Prevalence The increas...
Read more